Corstasis Therapeutics is a biopharmaceutical company that develops prescription therapeutics. The company advances small‑molecule and other drug candidates through preclinical and clinical development, with an emphasis on patient‑friendly dosage forms and outpatient use.
Its work spans discovery, formulation, clinical studies, and regulatory submissions, collaborating with contract manufacturers and drug‑delivery partners as needed. Corstasis operates at the intersection of chemistry and life sciences, applying pharmacology and formulation science to translate research into new treatment options.
